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ABSTRACT Calcium and phosphoinositide signaling regulate cell division in model systems, 
but their significance in mammalian cells is unclear. Calcium-binding protein-7 (CaBP7) is a 
phosphatidylinositol 4-kinaseIIIβ (PI4KIIIβ) inhibitor required during cytokinesis in mammalian 
cells, hinting at a link between these pathways. Here we characterize a novel association of 
CaBP7 with lysosomes that cluster at the intercellular bridge during cytokinesis in HeLa cells. 
We show that CaBP7 regulates lysosome clustering and that PI4KIIIβ is essential for normal 
cytokinesis. CaBP7 depletion induces lysosome mislocalization, extension of intercellular 
bridge lifetime, and cytokinesis failure. These data connect phosphoinositide and calcium 
pathways to lysosome localization and normal cytokinesis in mammalian cells.
INTRODUCTION
Phosphoinositides (PIs) constitute <1% of cellular lipid in mamma-
lian cells but are important mediators of many signaling pathways 
(Balla, 2013). Phosphatidylinositiol 4-phosphate (PI4P), one of seven 
possible PIs, can exert biological effects through either induction of 
local membrane curvature (Furse et al., 2012; important for trans-
port vesicle biogenesis) or recruitment of signaling proteins harbor-
ing PI4P-selective binding domains (Lenoir and Overduin, 2013).
Golgi-localized PI4KIIIβ is the most extensively studied PI4K iso-
form and, along with its yeast homologue pik1, functions in secretory 
cargo trafficking from the trans-Golgi network (TGN; Walch-Solimena 
and Novick, 1999; Haynes et al., 2005). PI4KIIIβ is a soluble enzyme 
recruited to the TGN by the small GTPase ADP-ribosylation factor 1 
(ARF1; Godi et al., 1999). ARF1 activates PI4KIIIβ to drive PI4P pro-
duction and biogenesis of secretory vesicles. PI4KIIIβ regulation at 
the TGN in mammalian cells is further influenced by two Ca2+-bind-
ing proteins, neuronal calcium sensor-1 (NCS-1; a Ca2+-dependent 
activator) and CaBP7 (a Ca2+-independent inhibitor; Zhao et al., 
2001; Haynes et al., 2005; Mikhaylova et al., 2009).
CaBP7 is an EF-hand containing, Ca2+-binding protein (McCue 
et al., 2010a,b, 2012). It is involved in the biogenesis of vesicular 
carriers from the TGN in neuronal cells, consistent with its function 
as a PI4KIIIβ regulator (Mikhaylova et al., 2009). CaBP7 also appears 
to regulate cytokinesis in mammalian cells (Neumann et al., 2010), 
although how it achieves this remains to be determined. Cytokinesis 
is fundamental for normal cellular growth, development, and aging. 
Defects in this process can ultimately lead to a state of aneuploidy 
and cellular transformation (Ly et al., 2000; Baker et al., 2005; Pfau 
and Amon, 2012; Ricke and van Deursen, 2013).
Studies in model organisms have demonstrated PI4KIIIβ activity 
is important during cytokinesis (Polevoy et al., 2009; Brill et al., 
2011; Echard, 2012). Evidence that PI4P is required during mitosis in 
mammalian cells derives from studies examining knockdown of the 
sole PI4P phosphatase, Sac1. Sac1 depletion in HeLa cells disrupts 
Golgi morphology and generates mitotic spindle defects (Liu et al., 
2008). PI4P is an important factor during mitosis, and evidence from 
nonmammalian systems indicates that PI4KIIIβ may be the enzyme 
regulating its production.
Recently it was reported that a pool of PI4KIIIβ localizes to lyso-
somes (Sridhar et al., 2013). Lysosomes were long considered a ter-
minal destination of the secretory pathway where cellular material 
consigned for recycling was trafficked. Accumulating evidence sug-
gests that these organelles have additional, nondegradative, func-
tions, including acting as Ca2+-signaling platforms (Galione et al., 
2010; McCue et al., 2013) and as lipid reservoirs during membrane 
repair events (Holt et al., 2006; Luzio et al., 2007b).
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RESULTS
CaBP7 localization in HeLa cells
In a previous study characterizing CaBP7 membrane targeting (Mc-
Cue et al., 2011), we consistently observed a subpopulation of HeLa 
cells in which CaBP7 localized to vesicular structures in addition to 
the TGN. To identify these vesicles, we examined the localization of 
CaBP7 with defined subcellular markers (Figure 1). Initially, mono-
meric cherry fluorescent protein (mCh)–tagged CaBP7 was coex-
pressed with yellow fluorescent protein (YFP)–tagged markers. No 
colocalization was observed between mCh-CaBP7 and the early 
endosome marker Rab5a–enhanced YFP (EYFP; Figure 1Ai) or the 
autophagosome marker LC3β-EYFP (Figure 1Aii). Degrees of colo-
calization were observed between mCh-CaBP7 and the late endo-
some/lysosome markers LAMP1-EYFP and green fluorescent pro-
tein (GFP)–VAMP7 (Figure 1A, iii and iv). CaBP7 localization in this 
analysis was variable and ranged from entirely vesicular in some 
cells to a mixed Golgi/vesicular distribution in others (Figure 1, Ai, 
In this article, we show that CaBP7 undergoes a cell cycle–de-
pendent redistribution from the Golgi apparatus at interphase to 
lysosomes during mitosis and to a mixed Golgi/lysosomal localiza-
tion at cytokinesis. We report that lysosomes positive for CaBP7 
cluster to either side of the intercellular bridge during cytokinesis 
and that CaBP7 depletion blocks both this clustering and the final 
abscission step to generate aneuploid cells. More specifically, 
CaBP7 loss of function appears to extend intercellular bridge life-
time, leading to abscission failure as determined in time-resolved 
live-cell imaging experiments. Cytokinesis is also inhibited by 
overexpression of wild-type PI4KIIIβ and by the PI4KIIIβ activators 
ARF1 and NCS-1 but not by overexpression of wild-type CaBP7 or 
a catalytically inactive version of PI4KIIIβ. This is the first demon-
stration that PI4KIIIβ activity regulates cytokinesis in mammalian 
cells and points to the intriguing possibility that lysosome activity 
in close proximity to the intercellular bridge plays an essential role 
in this process.
FIGURE 1: CaBP7 localization in HeLa cells. (A) Cells were transfected with mCh-CaBP7 along with EYFP-tagged Rab5a 
(i), LC3β (ii), LAMP1 (iii), or GFP-VAMP7 (iv). In overlays, mCh-CaBP7 is shown red and YFP/GFP markers in green. Inset 
in (iv) is an enlarged region of interest (ROI). (B) Cells transfected with mCh-CaBP7 were stained with the antibodies 
i) anti-HRS, ii) anti-Rab11, iii) anti-CD63, and iv) anti-LAMP1. mCh-CaBP7–transfected cells were also labeled with 
LysoTracker Blue (v, blue) before live-cell imaging (inset is an enlarged ROI). mCh-CaBP7 signal is red in all overlays, 
and antibody staining is green. Regions of colocalization are yellow for red/green channel overlap or pink for red/blue 
channel overlap. Scale bars, 10 μm.
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HeLa cells transfected with CaBP7 and LAMP1 (Figure 3 and Supple-
mental Movie S1). Consistent with these data, PI4KIIIβ exhibited a 
similar localization profile during mitosis and cytokinesis (Figure 4). 
PI4KIIIβ concentrated in a perinuclear patch at interphase (the TGN). 
There was partial colocalization with LAMP1 in interphase cells, and 
during metaphase and telophase both proteins remained partially 
colocalized, consistent with a pool of PI4KIIIβ residing on lysosomes 
during mitosis. The derived Pearson’s coefficients further highlight 
that of all markers assessed, CaBP7 colocalized to the greatest ex-
tent with the lysosomal marker LAMP1.
CaBP7 reduces PI4P levels and clusters lysosomes 
Knowing that CaBP7 and PI4KIIIβ target to lysosomes, we examined 
whether CaBP7 could modulate PI4P levels in cells. Cells were trans-
fected with mCh-CaBP7 and PI4P levels assessed with a PI4P-spe-
cific antibody (Figure 5A). On average, there was 58% reduction in 
PI4P-positive vesicle number in the presence of mCh-CaBP7 com-
pared with controls (average 20.9 ± 1.6 PI4P particles/cell for mCh-
CaBP7–transfected cells vs. average 49.9 ± 3.4 PI4P particles/cell for 
untransfected cells; Figure 5C). Because PI4P is a major precursor of 
phosphatidylinositol 4,5-bisphosphate (PIP2) production, a promi-
nent inositol lipid–signaling species with described functions during 
cytokinesis (Brill et al., 2011; Echard, 2012), we next addressed 
whether CaBP7 might indirectly modulate levels of this lipid as a 
consequence of reducing PI4P production. Cells were transfected 
with mCh-CaBP7, and PIP2 levels were assessed with a PIP2-specific 
antibody (Figure 5B). Although we observed a small reduction in 
cellular PIP2, this was not statistically significant compared with PIP2 
levels observed in untransfected control cells from the same experi-
ment (Figure 5C). We also attempted to confirm the influence of 
CaBP7 overexpression on cellular PI4P levels by dot blot analysis 
using a PIP-Strip–based method (Supplemental Figure S1). No dis-
cernible difference in total cellular PI4P between control and CaBP7-
transfected cells was observable using this approach. This is likely 
vesicular, vs. Aiv, vesicular and Golgi). Similar data were obtained 
with endogenous markers (Figure 1B). mCh-CaBP7 did not localize 
with the multivesicular body protein HRS (Figure 1Bi) or the recy-
cling endosome marker Rab11 (Figure 1Bii). Extensive colocalization 
of mCh-CaBP7 was observed with late endosome/lysosome mark-
ers LAMP1 and CD63 (Figure 1B, iii and iv). CaBP7 exhibited signifi-
cant colocalization with LysoTracker Blue, which specifically labels 
endolysosomal compartments (Figure 1Bv). Collectively these data 
indicate that a significant proportion of CaBP7-positive vesicles are 
late endosomes/lysosomes.
CaBP7 exhibits cell cycle–dependent subcellular localization
To understand CaBP7’s heterogeneous pattern of localization (see 
prior discussion), we examined its subcellular distribution with Golgi 
or lysosome markers during cell division. Because CaBP7 functions 
during cytokinesis (Neumann et al., 2010), we reasoned that it might 
traffic in a cell cycle–dependent manner. Initially, the distribution of 
endogenous CaBP7 with the TGN marker p230 was assessed (Figure 
2A). At interphase, there was colocalization of CaBP7 with p230 in a 
perinuclear region consistent with the TGN. At metaphase, p230 
immunoreactivity was lost due to Golgi fragmentation; however, 
CaBP7 remained associated with vesicles. By early telophase, the 
Golgi apparatus had begun to reform, and CaBP7 partially colocal-
ized with p230. At late telophase, the Golgi had fully reformed, and 
CaBP7/p230 partially colocalized to a level comparable to that ob-
served during interphase (Figure 2A and Supplemental Table S1). 
Cell cycle–dependent localization of CaBP7 with the lysosomal 
marker LAMP1 was also tested (Figure 2B). At interphase, there was 
partial colocalization of these proteins (Supplemental Table S1). Co-
localization increased at metaphase (explaining CaBP7 localization 
to vesicles in the absence of the Golgi). Colocalization increased 
further during early telophase and began to decline at late telo-
phase (Supplemental Table S1). These observations were mirrored 
in live-cell imaging experiments monitoring mitotic progression in 
FIGURE 2: Distribution of endogenous CaBP7 with TGN and lysosomal markers during the cell cycle in fixed and live 
HeLa cells. (A) Cells were fixed and stained with DAPI (blue), anti-p230 (green), or anti-CaBP7 (red) antibodies. (B) Cells 
were fixed and stained with DAPI (blue), anti-LAMP1 (green). and anti-CaBP7 (red). Colocalization appears yellow in 
overlays. Scale bars, 10 μm.
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CaBP7, Ca2+-deficient EF-hand mutants of CaBP7 and a kinase-dead 
PI4KIIIβ mutant can induce lysosome clustering, suggesting an effect 
on lysosomal PI4P (Supplemental Figure S2 and Supplemental Table 
S2). This was specific to lysosomes, since organelles earlier in the 
endolysosomal pathway were unaffected (Supplemental Figure S3).
CaBP7 and PI4P function during mitotic cell division (Liu et al., 
2008; Neumann et al., 2010; Brill et al., 2011; Echard, 2012). Be-
cause CaBP7 lowered PI4P levels and induced lysosome clustering, 
we examined potential connections between CaBP7, lysosomes, 
and mitosis. We first examined the distribution of CaBP7 during mi-
tosis (Figure 6A). At interphase, CaBP7, as expected, localized to 
vesicles and a perinuclear region, consistent with the TGN. From 
metaphase through to completion of anaphase, CaBP7-positive 
structures aggregated and moved toward the cell periphery. At telo-
phase, these vesicles redistributed from the periphery to flank the 
intercellular bridge. These data are consistent with a previous study 
in which lysosomal clustering during cytokinesis was observed 
(Matteoni and Kreis, 1987). Colocalization of CD63-positive endoly-
sosomal compartments with CaBP7-positive vesicles was observed 
during all stages of mitosis (Figure 6B), suggesting that the majority 
of CaBP7 becomes lysosome associated during this process.
PI4KIIIβ activity influences normal completion of cytokinesis 
Knowing that CaBP7-positive lysosomes exhibit an organized redis-
tribution during cytokinesis and that CaBP7 controls PI4P levels in 
cells prompted us to examine the requirement for PI4KIIIβ activity 
during mitosis in HeLa cells (Supplemental Table S3 and Figure 7A). 
A previous study uncovered a role for CaBP7 during cytokinesis 
(Neumann et al., 2010), and we used the same analysis to examine 
the role of PI4KIIIβ and its effectors during HeLa cell cytokinesis. 
First, we confirmed that CaBP7 depletion causes cytokinesis failure. 
CaBP7 knockdown and control transfected cells were imaged, and 
those harboring more than one nucleus were scored as abnormal 
(Figure 7A). Expression of scrambled short hairpin RNA interference 
(shRNAi) generated an 8.4% abnormal nuclei frequency (ANF), 
which increased to 22.9% on CaBP7 knockdown (Figure 7B). This 
2.7-fold difference in ANF is consistent with the previous study 
(Neumann et al., 2010). Of importance, the cytokinesis defect gen-
erated by CaBP7 protein depletion could be rescued by coexpres-
sion of a shRNAi-resistant version of the protein (Supplemental 
Table S3 and Figure 7B).
If CaBP7 depletion affected cytokinesis through loss of PI4KIIIβ 
inhibition, then overexpression of wild-type PI4KIIIβ or its activators 
(NCS-1 and ARF1) should elicit the same phenotype. To test this 
hypothesis, we examined how overexpression of PI4KIIIβ and its ef-
fectors influenced cytokinesis (Figure 7C). EYFP control protein elic-
ited an 8.2% ANF, similar to that observed with control shRNAi ex-
pression (Supplemental Table S3 and Figure 7C). Overexpression of 
wild-type PI4KIIIβ and its activators NCS-1 and ARF1 (all predicted 
to increase PI4P production by PI4KIIIβ) generated ANFs of 17.9, 
19.6, and 13.5%, respectively (Figure 7C and Supplemental Table 
S2). Overexpression of PI4KIIIβD656A or CaBP7, both of which should 
antagonize endogenous PI4KIIIβ, generated ANFs similar to those 
observed with control EYFP expression (7.8 and 6.8% ANF; respec-
tively; Supplemental Table S3 and Figure 7C). These data are consis-
tent with the hypothesis that excessive activation of PI4KIIIβ impairs 
cytokinesis in mammalian cells.
Depletion of CaBP7 induces loss of lysosomal clustering 
at cytokinesis
To understand how CaBP7 loss of function elicits cytokinesis 
failure, we examined lysosome distribution during mitosis in 
due to a combination of 1) limited transfection efficiency, 2) hetero-
geneity of CaBP7 expression in cells that were transfected, and 3 
the CaBP7-regulated pool of PI4P representing a subpopulation of 
total cellular PI4P.
Inhibition of PI4KIIIβ to deplete PI4P results in clustering of lyso-
somes (Sridhar et al., 2013). Consistent with this expression of 
FIGURE 3: Live-cell imaging of cells transfected with CaBP7 and 
LAMP1 during mitosis. Cells were transfected with CaBP7-mCh (red) 
and LAMP1-EYFP (green) and imaged once every 11.67 min by 
confocal microscopy as described in Materials and Methods. Images 
are shown starting at frame 1 (F1), initiation of mitosis (prophase), 
through to frame 68, completion of cytokinesis. All images are 
additionally overlaid with the transmitted light channel to permit 
an assessment of cell morphology. Scale bars, 10 μm.
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Figure S4). Finally, we investigated whether loss of lysosomal 
clustering on CaBP7 depletion was specific for these organelles by 
examining the distribution of the TGN at cytokinesis (Figure 8, B 
and C). No difference in p230 distribution in cells at cytokinesis was 
observed between scrambled and CaBP7 knockdown conditions 
(Figure 8, B and C). Because we previously demonstrated that 
CaBP7 overexpression was able to deplete cellular PI4P levels in 
interphase cells (Figure 5A), we tested whether this was also 
observable in mitotic cells (Figure 8D). Indeed, overexpression of 
CaBP7 qualitatively reduced PI4P staining compared with that 
observed in untransfected control cells. These data suggest 
that CaBP7 can modulate PI4P levels during cytokinesis in HeLa 
cells.
Closer analysis of live-cell imaging data showed that in control, 
untransfected cells at cytokinesis, the intercellular bridge had an 
CaBP7-knockdown cells versus controls (Figure 8, A–C). Lysosomes 
cluster near the intercellular bridge at cytokinesis (Figures 2B and 
6B; Matteoni and Kreis, 1987). In shRNAi control cells, clustering 
was observed (Figure 8A). CaBP7 shRNAi–expressing cells exhib-
ited a marked loss of clustering at the intercellular bridge during 
cytokinesis (Figure 8A). This was quantified by calculating LAMP1 
fluorescence intensity in the intercellular bridge region (Figure 8C). 
Consistent data were acquired from live-cell experiments in which 
LysoTracker Red was monitored during mitosis and cytokinesis in 
cells depleted of CaBP7 and compared with untransfected cells on 
the same dish (Figure 9 and Supplemental Movies S2 and S3). Loss 
of LAMP1 fluorescence at the intercellular bridge was not due 
to CaBP7 shRNAi expression causing a reduction in lysosome 
numbers, as total cellular LAMP1 fluorescence was similar in both 
CaBP7 shRNAi and scrambled control cells (Supplemental 
FIGURE 4: Distribution of PI4KIIIβ with LAMP1 during mitosis. Cells were stained with anti-PI4KIIIβ antibody (red), 
anti-LAMP1 (green), and DAPI (blue). Inset regions in telophase overlay images are enlargements of the ROI highlighted 
(white dotted square). Cells are shown at stages of the cell cycle. Colocalization between LAMP1 and PI4KIIIβ appears 
yellow in overlay images. Scale bars, 10 μm.
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DISCUSSION
This study was initiated by the novel obser-
vation that in addition to association with 
the TGN, CaBP7 was present on various uni-
formly distributed cytoplasmic vesicles in 
some but not all cells (McCue et al., 2009). 
On closer inspection, we were able to iden-
tify the CaBP7-positive vesicles not as secre-
tory cargo carriers but, somewhat unexpect-
edly, as late endosomes/lysosomes. CaBP7 
has been implicated as a factor required for 
normal completion of cytokinesis in mam-
malian cells (Neumann et al., 2010). This led 
us to examine whether CaBP7 might exhibit 
cell cycle–dependent localization, which 
might also explain the heterogeneity in 
CaBP7 distribution between cells within a 
population. Our data indicate that during 
interphase, CaBP7 is Golgi and lysosome 
resident, but that as cells enter mitosis, the 
protein relocates to become more lyso-
somal. This shift in CaBP7 distribution be-
gins to reverse during cytokinesis, consis-
tent with a proportion of CaBP7 returning to 
the TGN at reestablishment of interphase. A 
recent study in mammalian cells reported 
that a biochemically distinct pool of PI4KIIIβ 
is lysosomally associated and its activity 
there is essential for lysosomal content sort-
ing (Sridhar et al., 2013). Based on our cell 
cycle–dependent localization data, a candi-
date PI4KIIIβ interaction partner localized to 
lysosomes was CaBP7. PI4KIIIβ is the only 
documented target for CaBP7, and we 
therefore reasoned that lysosomal CaBP7 
might regulate the PI4KIIIβ pool resident at 
these organelles. Consistent with this hy-
pothesis, we demonstrated that overexpres-
sion of CaBP7 significantly reduced cellular 
PI4P levels in both interphase and mitotic 
cells. These observations were corroborated 
and linked specifically to lysosomal PI4P by 
using a simple lysosomal clustering assay 
developed by Sridhar et al. (2013). We were 
able to show that CaBP7 overexpression 
elicited a similar lysosomal clustering phe-
notype observed when endogenous PI4KIIIβ 
activity is reduced through RNAi-mediated 
protein depletion (Sridhar et al., 2013) or 
overexpression of the dominant-negative, 
kinase-dead version of the enzyme (Sridhar 
et al., 2013; Supplemental Figure S1). 
Collectively these data are consistent with 
a model in which PI4KIIIβ activity, regulated 
at least in part by CaBP7, is able to control 
lysosomal positioning, a property that is misregulated through 
inhibition of the enzyme and depletion of a lysosomal pool of PI4P.
PI4KIIIβ has also been implicated as an important factor regulat-
ing mitosis and cytokinesis in a number of model organisms; how-
ever, the importance of PI4KIIIβ activity during the process of cell divi-
sion in mammalian cell systems has yet to be assessed. We sought to 
determine whether CaBP7 influenced cytokinesis via PI4KIIIβ, in light 
average lifetime of 25.2 ± 2.4 min (Supplemental Movie S4 and 
Supplemental Figure S5). In contrast, cells depleted of CaBP7 ex-
hibited a 3.4-fold increase in the lifetime of the intercellular bridge 
(86.7 ± 9.0 min; Supplemental Movie S5 and Supplemental Figure 
S5). This could indicate that loss of CaBP7 induces a problem with 
bridge stability/assembly or abscission (Barr and Gruneberg, 2007; 
Mierzwa and Gerlich, 2014).
FIGURE 5: CaBP7 reduces PI4P but not PI4,5P2 levels in HeLa cells. Cells were transfected 
with mCh-CaBP7 (red; A, B) and stained with anti-PI4P antibody (green; A) or anti PI4,5P2 
antibody (green; B). The number of PI4P- and PI4,5P2-positive vesicles per cell was determined 
for mCh-CaBP7–transfected vs. untransfected cells on the same coverslip. Scale bars, 10 μm. 
(C) Quantification of data from A and B. All data are plotted as mean ± SEM. Untransfected 
control cells (n = 51) and mCh-CaBP7 transfected cells (n = 39) were analyzed from two 
independent experiments for PI4P samples. Untransfected control cells (n = 36) and mCh-
CaBP7–transfected cells (n = 36) were analyzed from two independent experiments for 
PI4,5P2 samples.
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lysosome clustering at the intercellular bridge during cytokinesis. It 
has been known for >25 yr that lysosomes cluster in a cell cycle–spe-
cific manner (Matteoni and Kreis, 1987), but why has remained a 
mystery. Lysosomes could conceivably mediate a degradative role 
to remove cytoskeletal components before membrane fission can 
proceed or provide a membrane reservoir required for completion 
of abscission, as shown for endosomes (Boucrot and Kirchhausen, 
2007). Lysosomes do exhibit membrane donor behavior during 
plasma membrane repair (McNeil and Kirchhausen, 2005; Luzio 
et al., 2007a). Lysosomes have also been recognized to mediate 
another key cellular role by acting as focal Ca2+-signaling platforms 
(Galione and Chuang, 2012; McCue et al., 2013). The role of Ca2+ 
during mitosis has been established in model cell systems (Miller 
et al., 1993; Whitaker, 2006); however, the significance of intracel-
lular Ca2+-signals during mammalian cell mitosis remains unclear. 
This report characterizes the novel finding that a specific Ca2+-bind-
ing protein directly affects normal cytokinesis through regulation of 
phosphoinositide signaling. Our observations raise a number of in-
teresting possibilities, and further work will be required to ascertain 
whether one or a combination of lysosomal activities (Ca2+ handling, 
recycling of cellular debris, membrane donation) contribute to cyto-
kinesis in mammalian cells.
of experimental evidence that disruption of PI4P levels is detrimental 
to this process in model organisms. We addressed potential func-
tional consequences of PI4KIIIβ activity and alterations in the pool of 
PI4P controlled by this kinase during HeLa cell mitosis and provided 
new evidence suggesting that it is an important factor in mammalian 
cell division. We were able to demonstrate that factors elevating PI4P 
production by PI4KIIIβ, including shRNAi-mediated depletion of en-
dogenous CaBP7 protein or overexpression of PI4KIIIβ or its activa-
tors, all disrupt cytokinesis and generate binucleate or multinucleate 
cells likely through stabilization of the intercellular bridge, incomplete 
bridge assembly, or defective abscission. The precise defect requires 
further examination of bridge-specific structures and whether their 
appearance is disrupted by loss of CaBP7 activity. Conversely, factors 
inhibiting PI4P production, including overexpression of exogenous 
CaBP7, have no effect on normal progression through mitosis and 
successful cytokinesis. Our findings are in contrast to those from 
Drosophila, in which PI4KIIIβ Fwd has been reported to be required 
for cytokinesis (Polevoy et al., 2009). Note, however, that this applied 
only to spermatocytes and not somatic cells and that part of the re-
quirement for Fwd was in a nonenzymatic capacity.
We showed that alterations in PI4KIIIβ activity can affect lyso-
somal dynamics and that loss of CaBP7 function prevents organized 
FIGURE 6: Distribution of CaBP7-positive vesicles during HeLa cell mitosis. (A) Cells were stained with DAPI (blue), 
anti-CaBP7 (red), and anti–α-tubulin (green). CaBP7 distribution was monitored at interphase and at defined points 
during mitotic cell division (metaphase through to late telophase—cytokinesis, arrowhead in anti-tubulin image 
highlights the intercellular bridge). CaBP7 and tubulin colocalization is yellow in overlay images. (B) Cells stained with 
DAPI (blue) were costained with anti-CaBP7 (red) and anti-CD63 (green) antibodies. CaBP7/CD63 distribution was 
characterized at interphase and in cells at metaphase, early telophase, and late telophase. CaBP7 and CD63 
colocalization is yellow in overlay images. Scale bars, 10 μm. 
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made by QuikChange site-directed mutagenesis according to 
the manufacturer’s protocol (Agilent, Santa Clara, CA). For 
mCh-CaBP7 EF1 and mCh-CaBP7 EF2 mutations, mCh-CaBP7 
was used as template with sense primer 5′-TTCATCCAAGCA-
GCAGCTGGGCACAGCCATG-3′ and antisense primer 5′-CATG-
GCTGTGCCCAGCTGCTGCTTGGAGATGAA-3′ and sense primer 
MATERIALS AND METHODS
Plasmid constructs
mCherry-CaBP7, CaBP7-mCherry (mCh-CaBP7/CaBP7-mCh), and 
EYFP-CaBP7 were generated as previously described (McCue 
et al., 2009). mCh-CaBP7 EFx2 (E56Q, E93Q) double mutation 
and EF 1 (E56Q) and EF2 (E93Q) single mutations were all 
FIGURE 7: PI4KIIIβ activity influences cytokinesis. (A) Cells transfected with constructs able to modulate PI4KIIIβ activity 
were stained with DAPI (red). Samples were scored for the number of multinucleate cells and cells at cytokinesis 
connected by an intercellular bridge. Cells were transfected with CaBP7 or scrambled control shRNAi plasmids. 
Silencing plasmids expressed GFP as a transfection marker (green). Overexpression of PI4KIIIβ, NCS-1, ARF1, 
PI4KIIIβD656A, and CaBP7 was also tested in this assay with EYFP as a control (all overexpressed constructs are green in 
overlays). Multinucleate cells are highlighted with an asterisk and cells undergoing cytokinesis with an arrowhead. Scale 
bars, 10 μm. (B) Quantification of shRNAi data from A. All data are plotted as mean ± SEM. Students unpaired t test 
analysis was performed for silencing data sets where CaBP7 knockdown and rescue were compared with scrambled 
control (p < 0.0001 for both conditions). (C) Quantification of overexpression conditions from A. Students unpaired 
t test analysis comparing each data set to the EYFP control condition generated p < 0.0001 in all instances, with the 
exception of ARF1, for which p = 0.0127. Statistical data are summarized in Supplemental Table S3.
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GTCAAGTGGACTT-3′. The plasmids encode a 29-mer shRNAi un-
der control of the human U6 promoter and a separate GFP reporter 
under the control of the CMV promoter for verification of transfec-
tion. shRNAi-resistant mCh-CaBP7 was generated by introduction 
of three silent point mutations using site-directed mutagenesis 
with sense primer 5′-GACATAGAGAACATaATtATGACaGAGGAG-
GAG-3′ and antisense primer 5′-CTCCTCCTCtGTCATaATtATGTT-
CTCTATGTC-3′. Point mutations are highlighted in boldface. All new 
plasmid constructs were verified by automated sequencing (Sequenc-
ing Service, University of Dundee, Dundee, United Kingdom).
Cell culture and plasmid transfections
HeLa cells were cultured in DMEM supplemented with 10% (vol/vol) 
fetal bovine serum, 1% (vol/vol) penicillin/streptomycin, and 1% 
(vol/vol) nonessential amino acids. All cells were maintained in a 
humidified atmosphere of 95% air/5% CO2 at 37°C. Cells were 
5′-CAAGTGGACTTTGAGCAGTTTGTGACCCTTCTG-3′ and anti-
sense primer 5′-CAGAAGGGTCACAAACTGCTCAAAGTCCAC-
TTG- 3′, respectively. For mCh-CaBP7 EFx2 double mutation, mCh-
CaBP7 EF1 was used as template with the sense primer and anti-
sense primer used for EF2 mutation generation. CaBP4-mCh, ARF1-
YFP, NCS1-YFP, and NCS-1-mCherry were described previously 
(Haynes et al., 2005; McCue et al., 2009; Handley et al., 2010). 
HA-PI4KIIIβ and the kinase-dead D656A mutant were as previously 
described (Godi et al., 1999). Rab5a-EYFP, LAMP1-EYFP, and 
LC3β-EYFP were as previously described (McCue et al., 2013). 
GFP-VAMP7 was a kind gift from T. Galli, Institut National de la 
Santé et de la Recherche Médicale (Paris, France). CaBP7 shRNAi 
and scrambled control shRNAi plasmids were from OriGene 
(Cambridge, United Kingdom). The sequence for scrambled 
shRNAi was 5′-GCACTACCAGAGCTAACTCAGATAGTACT-3′. The 
CaBP7-specific shRNAi sequence was 5′-GACATGGATGGTGATG-
FIGURE 8: Analysis of CaBP7 depletion on lysosome and Golgi localization during cytokinesis. (A) Cells transfected with 
control or CaBP7 shRNAi plasmids were stained with LAMP1 and α-tubulin antibodies. Cells at cytokinesis were imaged 
and LAMP1 fluorescence intensity in the region spanning the intercellular bridge (green lines in tubulin images) analyzed 
as described in Materials and Methods. (B) The same analysis from A was performed on cells stained for α-tubulin and 
the TGN marker p230. Dashed boxes highlight the enlarged region in the insets (top right corner of p230/LAMP1 
images). Scale bars, 10 μm. (C) Quantification of data from A and B. All data are plotted as mean ± SEM (n = 3 
independent experiments) and analyzed for statistical significance (scrambled control vs. CaBP7 shRNAi for both 
LAMP1 and p230 samples) using the Student’s unpaired t test. Total number of cells (n) analyzed across all three 
experiments is shown. (D) HeLa cells transfected with mCherry-CaBP7 (mCh-CaBP7, red) were costained with DAPI 
(blue) and anti-PI4P (green). Representative images for CaBP7- expressing and untransfected control cells from the 
same coverslips are shown for cells at early telophase. Scale bars, 10 μm.
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clonal anti–α-tubulin (1:500; AbCam); rabbit polyclonal anti–man-
nose-6-phosphate receptor (1:500; a kind gift from Paul Luzio, 
University of Cambridge, Cambridge, United Kingdom) and rabbit 
polyclonal anti-HRS (1:1000; a kind gift from Sylvie Urbé, University 
of Liverpool, Liverpool, United Kingdom). Primary antibodies were 
applied overnight at 4°C with gentle agitation. Cells were washed 
three times with 1 ml of PBS and twice with 1 ml of blocking solu-
tion and incubated with secondary goat anti-mouse immunoglobu-
lin G (IgG) conjugated to Alexa Fluor 488 or 405 for 1 h at room 
temperature (with the exception of FITC-conjugated anti-CD63). 
Coverslips were washed three times with 1 ml of PBS and then air 
dried and mounted onto microscope slides using Prolong. For anti-
PI4P staining, the staining protocol was modified as follows: Cells 
were fixed with 4% (vol/vol) formaldehyde/Tris-buffered saline (TBS; 
50 mM Tris-HCl, pH 7.4, 150 mM NaCl) for 20 min at room tem-
perature and washed subsequently three times with TBS. Permea-
bilization was achieved by incubating the cells with 0.5% (wt/vol) 
saponin in TBS at room temperature for 15 min. Cells were washed 
three times with TBS and then blocked with 10% (vol/vol) goat serum 
in TBS for 30 min at 37°C. Anti-PI4P antibody diluted in TBS was 
added to cells and incubated for 60 min at 37°C. Antibody was re-
moved and cells washed three times with 1% (vol/vol) goat serum in 
TBS before secondary antibody incubation (30 min at 37°C). Sec-
ondary antibody was also diluted in TBS. Cells were rinsed thor-
oughly with distilled water, air dried, and mounted onto micro-
scope slides with Prolong. Fixed cells were imaged using a Leica 
TCS-SP-MP confocal system (Leica Microsystems, Heidelberg, 
Germany) with pinhole set to 1 Airy unit and a 63× oil immersion 
objective with a numerical aperture of 1.3. Images were exported 
as TIFF files and compiled, processed, and analyzed with ImageJ 
and CorelDraw X6 applications.
plated onto sterile, 13-mm-round coverslips at a density of 0.25 × 
106 cells/well for fixation or directly onto 24-well tissue culture trays 
for Western blotting purposes. After 24 h, cells were transiently 
transfected with the indicated expression vectors using GeneJuice 
transfection reagent (Merck Millipore, Darmstadt, Germany) accord-
ing to the manufacturer’s protocol. For single and double transfec-
tions, 1 μg of each plasmid was used.
Immunofluorescence and imaging
At 24 h posttransfection (72 h for knockdown studies), cells on cov-
erslips were washed with phosphate-buffered saline (PBS; 137 mM 
NaCl, 2.7 mM KCl, 10 mM Na2PO4, 2 mM NaH2PO4, pH 7.4) and 
then fixed with 4% (vol/vol) formaldehyde in PBS for 6 min at room 
temperature. Coverslips were subsequently air dried and mounted 
onto microscope slides using Prolong antifade glycerol (with or 
without 4′,6-diamidino-2-phenylindole [DAPI] nuclear stain; Life 
Technologies, Paisley, UK). For immunofluorescence studies, cells 
were washed and fixed as described, followed by permeabilization 
with 0.2% (vol/vol) Triton-X-100 in PBS for 6 min at room tempera-
ture. Cells were washed extensively with PBS and twice with block-
ing solution (5% [wt/vol] bovine serum albumin [BSA] in PBS). 
Primary antibodies used were as follows: mouse monoclonal anti-
hemagglutinin (1:500; Sigma, Poole, United Kingdom); Mouse 
monoclonal anti-LAMP1 (1:400; AbCam, Cambridge, United King-
dom); mouse monoclonal anti-PI4P (1:100; Echelon Biosciences, 
Salt Lake City, UT); mouse monoclonal anti-PI4,5P2 (1:200; Echelon 
Biosciences); mouse monoclonal anti-CD63 fluorescein isothiocya-
nate (FITC) conjugate (1:200; AbCam); rabbit polyclonal anti-Rab11 
(1:500; Life Technologies); rabbit polyclonal anti-CaBP7 (1:200; 
Santa Cruz Biotechnology, Dallas, TX); mouse polyclonal anti-p230 
(1:200; BD Biosciences, Oxford, United Kingdom); mouse mono-
FIGURE 9: CaBP7 silencing prevents lysosome clustering during cytokinesis in live HeLa cells. HeLa cells were 
transfected with CaBP7-specific shRNAi plasmid and loaded with LysoTracker Red. The silencing plasmid additionally 
expressed GFP as a marker for transfection (not shown). A control untransfected cell and one that was GFP positive 
(CaBP7 shRNAi transfected) that subsequently underwent mitosis are highlighted with a white circle in frame 1 images. 
Lysosome clustering at cytokinesis is highlighted (arrowheads, F27) in control cells. Corresponding clustering was not 
observed at the same stage of mitosis in CaBP7 depleted cells (*, F36). In addition, an untransfected cell in the CaBP7 
silencing sample positioned directly beneath the CaBP7-depleted cell (green circle, F41) underwent normal mitosis and 
exhibited normal clustering of LysoTracker Red–positive vesicles. The CaBP7-depleted cell failed to complete 
cytokinesis successfully and became binucleate.
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with blocking buffer (BB; 3% [wt/vol] BSA in 0.1% [vol/vol] Tween-20/
PBS [PBS-T]) overnight at 4°C. The filter was then incubated with 0.5 
μg/ml PI4P-Grip protein (Echelon Biosciences) in BB for 1 h at room 
temperature with gentle agitation. After three washes with PBS-T, 
the filter was incubated with anti–glutathione S-transferase antibody 
(rabbit polyclonal; Sigma) diluted 1:500 in BB for 1 h at room tem-
perature with gentle agitation. The filter was subsequently washed 
three times with PBS-T and incubated with horseradish peroxidase–
conjugated anti-rabbit IgG (Sigma) diluted 1:400 in BB for 1 h at 
room temperature with gentle agitation. Bound protein was visual-
ized with enhanced chemiluminescence reagents.
Particle counting analysis
A representative untransfected control cell stained with anti-PI4P 
antibody was chosen and 25 randomly distributed PI4P positive par-
ticles selected. The diameters of these particles was determined us-
ing ImageJ, and the lower and upper limits of the range (8 and 15 
pixels, respectively) was subsequently used to set a range (8–15 
pixels) of particle diameters that would be detected by automated 
ImageJ counting. Particles having diameters smaller or larger than 
the limits of this range were therefore excluded from the analysis. 
For lysosomal clustering analysis, a minimum particle diameter of 10 
pixels was used, with the maximum value set to infinity.
Fluorescence colocalization analysis with JACoP
The ImageJ plug-in JACoP (Bolte and Cordelieres, 2006) was used 
to derive Pearson’s correlation coefficients for pairwise sets of image 
data. The Pearson’s coefficient under these circumstances measures 
the strength of relationship between pixels at the same location in 
two images being compared. Perfect correlation (colocalization) 
generates a correlation coefficient, R, of 1. Briefly, each image was 
first subjected to background subtraction before analysis with JA-
CoP. Costes’ randomization was simultaneously applied for each 
pair of images analyzed to ensure the validity of the correlation data. 
For all image pairs analyzed, the randomized control Pearson’s coef-
ficient was 0 ± 0.003.
Analysis of lysosome/Golgi localization during cytokinesis
GFP-positive cells (a transfection marker present in CaBP7 shRNAi 
and scrambled shRNAi plasmids) at cytokinesis (determined through 
α-tubulin intercellular bridge staining) were analyzed with ImageJ 
software and the plot profile application. A straight line across the 
intercellular bridge extending to the edge of the nucleus of each 
daughter cell was drawn on p230/LAMP1-stained sample images 
and the fluorescence profile along this line analyzed. The area under 
the curve for these profiles was calculated, which represents the av-
erage fluorescence intensity of p230/LAMP1 in the regions of the 
cytoplasm and intercellular bridge directly beneath the line. Data 
from scrambled shRNAi samples were normalized to 100% (control) 
and CaBP7 shRNAi fluorescence intensity calculated as a percent-
age of this. Whole-cell fluorescence data were also analyzed from 
the same cells by tracing a region of interest around the plasma 
membrane of each cell and quantifying the average p230/LAMP1 
fluorescence intensity over this area.
Lipid extraction and dot blot analysis
HeLa cells were plated onto 10-cm dishes and transfected with 5 μg 
of mCherry-N1 or 5 μg of mCherry-CaBP7. At 24 h posttransfection, 
cells (∼2.2 × 106 cells/dish) were trypsinized, collected, and homog-
enized in 1 ml of chloroform/methanol 2:1 (vol/vol). After dispersion, 
the mixture was agitated at room temperature) on an orbital shaker 
(30 rpm) for 15 min. The homogenate was centrifuged at 2400 × g 
for 3 min to recover the aqueous phase and the organic solvent 
washed with 200 μl of 0.9% (wt/vol) NaCl solution. After vortexing, 
the mixture was centrifuged at 380 × g to again separate organic/
aqueous phases. The upper phase was discarded and the interface 
surface rinsed twice with methanol/water 1:1 (vol/vol). The lower 
phase was subsequently centrifuged for 45 min at 43°C (medium 
drying rate) under vacuum to evaporate chloroform (SpeedVac 
SC210A). Lipid pellets were resuspended in 50 μl of chloroform/
methanol 2:1 (vol/vol). From this sample, two further dilutions (two-
fold and fourfold) were prepared. A 1-μl sample of each was spotted 
onto a PIP-Strip (Echelon Biosciences) between the lipid standards 
and allowed to dry completely. Once dried, the filter was incubated 
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Figure S1 – Dot blot analysis of cellular PI4P levels in cells over-expressing CaBP7. 
Total cellular lipid was extracted from HeLa cells overexpressing mCh-CaBP7 or mCh-
N1 control plasmid and spotted in the centre of a PIP-Strip™ phospholipid/lipid analysis 
membrane (dashed area in the centre of the filter). Undiluted (top spot in dashed area for 
mCh-CaBP7 and mCh-N1 samples) and a 2x and 4x dilution of this material (lower two 
spots for each sample respectively) were dried on to the membrane and probed for the 
presence of PI4P as described in materials and methods followed by detection by 
Western blotting. Lipids preloaded onto the PIP-Strip™ are as follows: GT: Glyceryl 
tripalmitate; DAG: Diacylglycerol; PA: Phosphatidic acid; PS: Phosphatidylserine; PE: 
Phosphatidylethanolamine; PC: Phosphatidylcholine; PG: Phosphatidylglycerol; CL: 
Cardiolipin; PI: Phosphatidylinositol; PI4P: Phosphatidylinositol 4-phosphate; PI4,5P2: 
Phosphatidylinositol 4,5-bisphosphate; PI3,4,5P3: Phosphatidylinositol 3,4,5-
trisphosphate; CHOL: Cholesterol; SM: Sphingomyelin; SUL: 3-
sulfogalactosylceramide. 
  
Figure S2 – CaBP7 regulates lysosomal PI4P levels as assessed by lysosomal clustering. 
A) PI4KIIIβ depletion causes lysosome clustering (Sridhar et al., 2013). If CaBP7 
inhibits lysosomal PI4KIIIβ then it too should induce clustering.  Cells were transfected 
with LAMP1-EYFP and: mCh-tagged CaBP4/CaBP7, HA-tagged PI4KIIIβD656A, single 
(mCh-CaBP7 EF1; mCh-CaBP7 EF2) or double (mCh-CaBP7 EFx2) EF-hand mutants of 
CaBP7. LAMP1-EYFP is depicted green and co-transfected proteins red. Co-localisation 
is yellow in overlays. LAMP1 positive structures were counted per cell which correlates 
with the extent of lysosome clustering. Scale bars=10μm. B) Quantification of (A). All 
data are plotted as mean ± S.E.M and normalised to control number of LAMP1 particles 
observed in CaBP4-mCh transfected cells (100%). For full statistical data see Table 2. 
Overexpression of CaBP7 reduced LAMP1 particle count 2.4 fold compared to CaBP4 
indicative of lysosomal clustering (Table 2, Figures S2Aii and S2B). In agreement with 
(Sridhar et al., 2013), expression of PI4KIIIβD656A induced LAMP1 clustering compared 
to CaBP4 (Table 2, Figures S2Aiii and S2B) the magnitude of which was similar to that 
observed with CaBP7 (1.9 fold). CaBP7 inhibition of PI4KIIIβ occurs in the absence of 
Ca2+ (Mikhaylova et al., 2009). Expression of CaBP7 with single or double EF-hand 
mutations also induced clustering of LAMP1 positive structures similar to wild-type 
protein indicating Ca2+ binding by CaBP7 is not required for regulation of lysosomal 
PI4KIIIβ (Table 2, Figures S2Aiv-vi and S2B).  
 
Figure S3 – CaBP7 does not cluster early/recycling endosomes.  
EYFP-CaBP7 failed to induce observable changes in the distribution or morphology of 
mannose-6-phosphate receptor (M6PR) positive recycling endosomes (S3i). CaBP4-mCh 
(S3ii) control or mCh-CaBP7 expression (S3iii) did not influence the distribution or 
morphology of Rab5a positive early endosomal compartments. We conclude from these 
data that CaBP7 overexpression does not induce clustering of endocytic compartments 
upstream of late endosomes/lysosomes. 
 
Figure S4 – CaBP7 does not influence lysosome numbers. Cells analysed for loss of 
lysosomal clustering (Figure 8A-C) were examined for total cellular fluorescence to 
ascertain if CaBP7 silencing reduced LAMP1 fluorescence through depletion of 
lysosomes from cells and not mislocalisation. LAMP1 and p230 data sets have been 
normalised to the corresponding scrambled shRNAi control data (100%). All data are 
plotted as mean ± SEM. N numbers are as described in Figure 8C. 
 
Figure S5 – Enhanced lifetime of the intercellular bridge in cells depleted of CaBP7. 
Cells from experiments depicted in Movies 4 and 5 were examined for the length of time 
they remained attached by a visible intercellular bridge upon reaching late telophase. Five 
untransfected control and three CaBP7 shRNAi expressing cells were analysed and the 
averaged data plotted as a histogram. All data are presented as mean±SEM. 
 
 
 
 
 
 
Table 1 – Pearson’s correlation coefficients for data from Figures 2 and 4. The ImageJ 
plug-in JACoP was used to compare fluorescence distribution in images from figures 2A, 
2B and 4 as described in the methods section.   
Pearson’s correlation coefficient (R) Table 1 
Stage of cell cycle 
Figure 2A – Anti-
p230 + Anti-
CaBP7 
Figure 2B – Anti-
LAMP1 + Anti-
CaBP7 
Figure 2D – Anti-
LAMP1 + Anti-
PI4KIIIβ 
Interphase 0.37 0.63 0.51 
Metaphase 0.20 0.68 0.48 
Early Telophase 0.28 0.72 0.55 
Late Telophase 0.42 0.59 0.46 
 
 
 
 
 
Table 2 – Particle count numerical and statistical data for LAMP1 clustering analysis 
described in Figure S2. 
Construct LAMP1 
particle 
count 
(%) 
± SEM 
(%) 
Fold 
reduction 
compared to 
control 
Cells 
analysed 
Number of 
independent 
experiments
p 
CaBP4 100 11.1 1.0 109 3 - 
CaBP7 41.7 2.9 2.4 102 3 <0.0001 
PI4KIIIβ- 52.7 1.5 1.9 97 3 <0.0001 
D656A 
CaBP7-
EF1 
58.5 10.6 1.7 86 3 0.00087 
CaBP7-
EF2 
57.5 3.6 1.7 120 3 0.0002 
CaBP7-
EFx2 
49.5 8.7 2.0 123 3 0.0004 
 
 
 
Table 3 – Numerical and statistical data for PI4KIIIβ activity during mitosis from Figure 
7A-C. 
Construct Abnormal 
nuclei (%) 
± 
SEM 
(%) 
Fold 
reduction 
compared 
to CaBP7 
silencing 
Cells 
analysed
Number of 
independent 
experiments 
p 
Control 
siRNA 
8.4 2.0 2.7 1269 3 - 
CaBP7 
siRNA 
22.9 0.6 1.0 1108 3 <0.0001
CaBP7 
rescue 
11.4 2.6 2.0 262 3 <0.0001
EYFP  8.2 0.5 2.8 562 3 - 
PI4KIIIβ 17.9 1.2 1.3 785 4 <0.0001
NCS-1 19.6 1.5 1.2 353 3 <0.0001
ARF1 13.5 2.8 1.7 288 3 0.0127 
PI4KIIIβ-
D656A 
7.8 1.3 2.9 896 3 <0.0001
CaBP7 6.8 2.4 3.4 350 3 <0.0001
 
